Medical Microbiology I - Lecture10

50
MEDICAL MICROBIOLOGY I Lesson 10 Lesson 10 Neisseria and Diseases

description

Notes

Transcript of Medical Microbiology I - Lecture10

  • MEDICAL MICROBIOLOGY I

    Lesson 10Lesson 10

    Neisseria and Diseases

  • Neisseria

    2 species, Neisseria gonorrhoeae and

    Neisseria meningitidis are strictly human

    pathogens

    The remaining 8 species are commonly The remaining 8 species are commonly

    present on mucosal surfaces of the

    oropharynx and nasopharynx, and

    occasionally colonise the anogenital mucosal

    membranes

  • Neisseria

    Characteristics:

    Aerobic

    Gram negative cocci (diplococci) with adjacent sides

    flattened together (resembling coffee beans)flattened together (resembling coffee beans)

    Non-motile

    Do not form endospore

    Oxidase-positive

    Most produce catalase (combine with the Gram

    stain morphology allow for a rapid, presumptive

    identification of a clinical isolate)

  • Neisseria

  • Neisseria gonorrhoeae

  • Neisseria gonorrhoeae

    1. Physiology and Structure

    N. gonorrhoeae is a fastidious organism, requiring complex media for growth and adversely affected by drying and fatty acids

    Optimal growth temperature: 35 - 37C Optimal growth temperature: 35 - 37C

    A humid atmosphere supplemented with carbon dioxide is either required or enhances growth of N. gonorrhoeae

    Cell wall: thin peptidoglycan layer sandwiched between the inner cytoplasmic membrane and the outer membrane

  • Neisseria gonorrhoeae

    The outer membrane is not covered with a

    true carbohydrate capsule, as is found in N.

    meningitidis

    Cell surface-capsule like negative charge Cell surface-capsule like negative charge

    Fresh clinical isolates have pili (virulence

    factor)

    The pili are composed of repeating protein

    subunits (pilins), whose expression is

    controlled by pil gene complex

  • Neisseria gonorrhoeae

    Pili mediate attachment to non-ciliated

    epithelial cells as well as provide resistance to

    killing neutrophils

    The Por proteins (formerly protein I) are porin The Por proteins (formerly protein I) are porin

    proteins that form pores or channels in the

    outer membrane

    2 classes: PorA (resistant to serum killing and

    thus are commonly associated with

    disseminated disease) and PorB

  • Neisseria gonorrhoeae

    Opa proteins (opacity proteins; formerly

    protein II) are family of membrane proteins

    that mediate binding to epithelial cells

    Bacteria expressing the Opa proteins appear Bacteria expressing the Opa proteins appear

    opaque when grown in culture

    These proteins facilitate bacterial adherence to

    each other and to eukaryotic cells

  • Neisseria gonorrhoeae

    RMP proteins - highly conserved; reduction-

    modifiable proteins; formerly protein III

    These protein stimulate antibodies that block

    serum bacterial activity against N. gonorrhoeaeserum bacterial activity against N. gonorrhoeae

    Others: lipooligosaccharide (LOS), lipid A, -

    lactamase which degrades penicillin

  • Neisseria gonorrhoeae

    2. Pathogenesis and Immunity

    Gonococci attach to mucosal cells, penetrate into the cells and multiply, and then pass through the cells into the sub-epithelial space, where infection is establishedspace, where infection is established

    Pili - virulence; non-piliated - avirulent

    After the initial attachment, Opa protein directs first a tighter association with the host cell surface and then the migration of bacteria into the epithelial cell

  • Neisseria gonorrhoeae

  • Neisseria gonorrhoeae

    It was believed that the Por protein protects

    the phagocytosed bacteria from intracellular

    killing by inhibiting phagolysosome fusion

    The gonococcal LOS stimulates the The gonococcal LOS stimulates the

    inflammatory response and release of tumour

    necrosis factor- (TNF-), which causes most

    of the symptoms associated with gonococcal

    disease

  • Neisseria gonorrhoeae

    IgG3 is the predominant IgG antibody formed in

    response to gonococcal infection

    Antibodies to LOS can activate complement,

    releasing complement component C5a, which has releasing complement component C5a, which has

    a chemotactic effect on neutrophils

    IgG and secretory IgA1 antibodies directed against

    Rmp protein can block this bacteridal antibody

    response

    People with inherited complement deficiencies are

    at considerably greater risk for systemic disease

  • Clinical Diseases

    Genital infection in men is primarily restricted to the urethra

    A purulent urethral discharge and dysuria develop after a 2-5 days incubation perioddevelop after a 2-5 days incubation period

    Approximately 95% of all infected men have acute symptoms

    Although complications are rare, epididymitis, prostatitis, and periurethral abscesses can occur

  • Clinical Diseases

  • Clinical Diseases

    The primary site of infection in women is the cervix because the bacteria infect the endocervical columnar epithelial cells

    The organism cannot infect the squamous epithelial cellsepithelial cells

    Symptoms: vaginal discharge, dysuria, and abdominal pain

    Ascending genital infection: salpingitis, tuboovarian abscesses, and pelvic inflammatory disease (10 - 20% women)

  • Clinical Diseases

    Disseminated infections with septicaemia and infection of skin and joints occur in 1 - 3% of infected women and in a much lower percentage of infected men

    Clinical manifestations of disseminated disease: Clinical manifestations of disseminated disease: fever, migratory arthralgias, suppurative arthritis in the wrists, knees and ankles, and a pustular rash on a erythematous base over the extremities but not on the head and trunk

    N. gonorrhoeae is a leading cause of purulent arthritis in adult

  • Clinical Diseases

  • Clinical Diseases

    Other diseases associated with N.

    gonorrhoeae:

    Perihepatitis (Fitz-Hugh-Curtis syndrome)

    Purulent conjunctivitis, particularly in Purulent conjunctivitis, particularly in

    newborns infected during vaginal delivery

    (opthalmia neonatorum)

    Anorectal gonorrhoea in homosexual men and

    pharyngitis

  • Laboratory Diagnosis

    Microscopy: Gram stain

    Culture: Thayer-Martin medium, chocolate agar

    Identification: oxidase-positive (acid produced Identification: oxidase-positive (acid produced oxidatively from glucose but not from other sugars), Gram negative diplococci that grow on chocolate agar

    Genetic probes: sensitive, rapid (2 - 4 hrs)

    Serology: gonococcal antigen-antibody detected; not recommended

  • Neisseria gonorrhoeae

  • Neisseria meningitidis

    1. Physiology and Structure

    The meningococci form transparent, non-pigmented colonies on chocolate agar, and their growth is enhanced in a moist atmosphere with 5% carbon dioxideatmosphere with 5% carbon dioxide

    Isolates with large polysaccharide capsules appear as mucoid colonies

    Meningococci are oxidase-positive and are differentiated from other Neisseria species by the production of acid from oxidation of glucose and maltose but not sucrose or lactose

  • Neisseria meningitidis

  • Neisseria meningitidis

    N. meningitidis is subdivided into serogroups and serotypes

    13 serogroups, with antigenic differences in their polysaccharide capsule, have been describeddescribed

    A, B, C, X, Y and W135

    The serotype classification of isolates is based on differences in the proteins in the outer membrane and in the oligosaccharide component of LOS

  • Neisseria meningitidis

    Serotype classification has proven useful for

    epidemiologic classification and for the

    characterisation of virulent strains

    All group A meningococci have the same outer- All group A meningococci have the same outer-

    membrane proteins and belong to a single

    serotype, whereas the meningococci in group

    B and C belong to multiple serotypes

  • Neisseria meningitidis

    2. Pathogenesis and Immunity

    The outcome in a person exposed to N. meningitidis depends on the following 4 factors:

    Whether the bacteria are able to colonise the nasopharynx (mediated by pili)nasopharynx (mediated by pili)

    Whether specific group- and serotype-specific antibodies are present

    Whether systemic spread occurs without antibody-mediated phagocytosis (protection afforded by polysaccharide capsule)

    Whether toxic effects (mediated by the LOS endotoxin) are expressed

  • Neisseria meningitidis

    Experiments with nasopharyngeal tissue organ

    cultures have shown that meningococci attach

    selectively to specific receptors for

    meningococcal pili on non-ciliated columnar meningococcal pili on non-ciliated columnar

    cells of the nasopharynx

    Meningococci without pili are less able to bind

    these cells

  • Neisseria meningitidisMeningococcal disease occurs in the absence of

    specific antibodies directed against the

    polysaccharide capsule and other expressed

    bacterial antigens

    Infants are initially afforded protection by the

    passive transfer of maternal antibodiespassive transfer of maternal antibodies

    Immunity can be stimulated by colonisation with

    N. meningitidis or other bacteria with cross-

    reactive antigens (e.g. colonisation with N.

    meningitidis sp; exposure to E. coli K1 antigen,

    which cross-reacts with the group B capsular

    polysaccharide)

  • Neisseria meningitidis

    Bactericidal activity also requires the existence

    of complement

    Patients with deficiencies in C5, C6, C7, or C8 of

    the complement system are estimated to be at a the complement system are estimated to be at a

    6000-fold greater risk for meningococcal disease

    Meningococci are internalised into phagocytic

    vacuoles and are able to avoid intracellular

    death, replicate, and then migrate to the sub-

    epithelial spaces

    Protection: anti-phagocytic capsule

  • Neisseria meningitidis

    The vascular wall damage associated with meningococcal infection (e.g. endothelial damage, inflammation of vessel walls, thrombosis, disseminated intravascular coagulation) is largely attributed to the action coagulation) is largely attributed to the action of the LOS endotoxin present in the outer membrane

    N. meningitidis produces excess membrane fragments that are released into the extracellular space

  • Neisseria meningitidis

    This continuous hyper production and release

    of endotoxin may cause the severe endotoxic

    reaction seen in patients with meningococcal

    diseasedisease

  • Clinical Diseases

    Meningitidis

    The disease usually begins abruptly with headache, meningeal signs, and fever

    Very young children may have only non- Very young children may have only non-specific signs, such as fever and vomiting

    Mortality approaches 100% in untreated patients but is less than 10% in patients in whom appropriate antibiotic therapy is instituted promptly

  • Clinical Diseases

    The incidence of neurologic sequelae is low,

    with hearing deficits and arthritis most

    commonly

  • Clinical Diseases

    Meningococcemia

    Septicaemia with or without meningitis is a

    life-threatening disease

    Thrombosis of small blood vessels and multi- Thrombosis of small blood vessels and multi-

    organ involvement are characteristic clinical

    features

  • Clinical Diseases

  • Clinical Diseases

    Small petechial skin lesions on the trunk and

    lower extremities are common and may

    coalesce to form larger haemorrhagic lesions

    Overwhelming disseminated intravascular Overwhelming disseminated intravascular

    coagulation with shock, together with the

    bilateral destruction of the adrenal glands

    (Waterhouse-Friderichsen syndrome), may

    ensue

  • Clinical Diseases

    A milder, chronic septicaemia has also been

    observed

    Bacteremia can persist for days or weeks, and

    the only signs of infection are a low-grade the only signs of infection are a low-grade

    fever, arthritis, and petechial skin lesions

    The response to antibiotic therapy in patients

    with this form of the disease is generally

    excellent

  • Clinical Diseases

    Other syndromes

    Pneumonia, arthritis, and urethritis

    Meningococcal pneumonia is usually preceded by a respiratory tract infection

    Symptoms: cough, chest pain, rales, fever and Symptoms: cough, chest pain, rales, fever and chills

    Evidence of pharyngitis is observed in most affected patients

    Prognosis in patients with meningococcal pneumonia is good

  • Laboratory Diagnosis

    Most useful specimens for the detection of

    meningococci are blood and cerebrospinal

    fluid (CSF)

    Although the organism is present in the blood Although the organism is present in the blood

    of most patients with systemic disease,

    additives in blood culture broths can be toxic

    for Neisseria and can therefore inhibit or delay

    bacterial growth

  • Laboratory Diagnosis

    Because the bacterial count in CSF is high, the Gram negative diplococci are readily seen within polymorphonuclear leukocytes on Gram stain

    Counter-immunoelectrophoresis or the agglutination of latex particles used to detect soluble polysaccharide antigen

    N. meningitidis is relatively non-immunogenic and does not react with the test antigens

  • Treatment, Prevention and Control

    Antibiotic therapy and supportive management for the complications of meningococcal disease have significantly reduced the mortality associated with the diseasedisease

    Sulfonamides - successful; however, widespread resistance to the agents has now negated their effectiveness

    Penicillin - more common; resistancy also becoming common

  • Treatment, Prevention and Control

    Because penicillin therapy remains effective

    against most of these isolates, the clinical

    significance of low-level resistance is unknown

    Resistance to chloramphenicol and rifampin Resistance to chloramphenicol and rifampin

    has been observed, so isolates from patients

    whose does not respond to empirical therapy

    should be evaluated carefully for antibiotic

    resistance

  • Treatment, Prevention and Control

    Eradication of the pool of healthy carriers of

    N. meningitidis is unlikely

    Therefore, efforts have been concentrated on

    the prophylactic treatment of people exposed the prophylactic treatment of people exposed

    to diseased patients and on the enhancement

    of immunity to the serogroups most

    commonly associated with the disease

  • Treatment, Prevention and Control

    Sulfonamides were used for prophylaxis, but now

    they are no longer considered reliable

    Penicillin is ineffective in eliminating the carrier

    statestate

    Minocycline and rifampin have been effectively for

    antibiotic-mediated chemoprophylaxis because

    these antibiotics are secreted into the mucus

    However, toxic effects have been associated with

    minocycline, and rifampin-resistant N. meningitidis

    can arise during treatment

  • Treatment, Prevention and Control

    Prophylaxis with a sulfonamide is

    recommended for people exposed to

    susceptible strains, with rifampin used for

    those with sulfonamide-resistant strainsthose with sulfonamide-resistant strains

    Vaccines directed against the group-specific

    capsular polysaccharides have been

    developed for antibody-mediated

    immunoprophylaxis

  • Treatment, Prevention and Control

    A polyvalent vaccine effective against

    serogroups A, C, Y, and W135, which can be

    administered to children older than 2 years,

    has been developedhas been developed

    The vaccine cannot be administered to

    children in younger age groups because they

    do not respond to polysaccharide antigens

  • Treatment, Prevention and Control

    The group B polysaccharide is a weak immunogen and cannot induce a protective antibody response

    Thus, immunity to group B N. meningitidis must develop naturally after exposure to cross-develop naturally after exposure to cross-reacting antigens

    Vaccination with a suspension containing serogroup A can be used for control of an outbreak of disease, for travelers to hyper-endemic areas, or for people at increased risk for disease

  • Other Neisseria Species

    Neisseria species such as Neisseria sicca and

    N. mucosa are commensal organisms in the

    oropharynx

    Implicated in isolated cases of meningitis, Implicated in isolated cases of meningitis,

    osteomyelitis, and endocarditis as well as

    bronchopulmonary infection, acute otitis

    media, and acute sinusitis

  • Other Neisseria Species

    The observation of many Gram negative

    diplococci associated with inflammatory cells

    in a well-collected respiratory specimen would

    support the etiologic role of these organismssupport the etiologic role of these organisms

    Most isolates of N. sicca and N. mucosa are

    susceptible to penicillin, although low-level

    resistance caused by altered penicillin-binding

    protein has been observed